OrbiMed Capital GP VI LLC
SEC CIK 1682115 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CMPX | Compass Therapeutics, Inc. | Dir, 10% | 0 | — | $5.68M | 1 | 2025-04-09 | 2025-04-09 |
| IRON | Disc Medicine, Inc. | Dir, 10% | 188.6K | — | $19.80M | 3 | 2022-12-29 | 2025-03-19 |
| NPCE | NeuroPace Inc | 10% | 3.50M | — | $7.34M | 3 | 2023-10-02 | 2024-04-16 |
| EWTX | Edgewise Therapeutics, Inc. | Dir, 10% | 14.44M | $5.99M | — | 2 | 2022-05-18 | 2024-01-23 |
| SPRY | ARS Pharmaceuticals, Inc. | Dir | 8.02M | $3.10M | — | 1 | 2023-08-29 | 2023-08-29 |
| IMA | ImageneBio, Inc. | Dir | 2.25M | -$1.13M | — | 2 | 2022-06-22 | 2023-08-04 |
Most active insiders at CMPX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Anderman Jonathan | GC | $47.2K | — |
| 2 | Lerner Neil | CAO | $28.4K | — |
| 3 | Shin Barry | CFO | — | — |
| 4 | Schuetz Thomas J. | CEO, Dir | — | — |
OrbiMed Capital GP VI LLC made no open-market trades at CMPX in the last 12 months.
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-04-11 | 2025-04-09 | CMPX | Compass Therapeutics, Inc. | OrbiMed Capital GP VI LLC | Dir, 10% | S - Sale | $1.59 | -3.57M | 0 | -100% | -$5.68M |
| MI | 2025-03-21 | 2025-03-19+ | IRON | Disc Medicine, Inc. | OrbiMed Capital GP VI LLC | Dir | S - Sale | $54.02 | -52.4K | 188.6K | -22% | -$2.83M |
| MI | 2025-03-12 | 2025-03-10+ | IRON | Disc Medicine, Inc. | OrbiMed Capital GP VI LLC | Dir | S - Sale | $54.31 | -312.4K | 539.8K | -37% | -$16.97M |
| MI | 2024-04-18 | 2024-04-16+ | NPCE | NeuroPace Inc | OrbiMed Capital GP VI LLC | 10% | S - Sale | $14.02 | -17.0K | 3.50M | -0.5% | -$238.2K |
| MI | 2024-04-15 | 2024-04-11+ | NPCE | NeuroPace Inc | OrbiMed Capital GP VI LLC | 10% | S - Sale | $14.49 | -485.0K | 3.54M | -12% | -$7.03M |
| I | 2024-01-25 | 2024-01-23 | EWTX | Edgewise Therapeutics, Inc. | OrbiMed Capital GP VI LLC | Dir, 10% | P - Purchase | $11.00 | +454.5K | 14.44M | +3% | +$5.00M |
| MI | 2023-10-04 | 2023-10-02+ | NPCE | NeuroPace Inc | OrbiMed Capital GP VI LLC | 10% | S - Sale | $9.07 | -8,314 | 4.00M | -0.2% | -$75.4K |
| DI | 2023-09-14 | 2023-08-04 | IMA | ImageneBio, Inc. | OrbiMed Capital GP VI LLC | Dir | A - Grant | — | +153.1K | 2.25M | +7% | — |
| I | 2023-08-31 | 2023-08-29 | SPRY | ARS Pharmaceuticals, Inc. | OrbiMed Capital GP VI LLC | Dir | P - Purchase | $6.20 | +500.0K | 8.02M | +7% | +$3.10M |
| MI | 2023-01-03 | 2022-12-29 | IRON | Disc Medicine, Inc. | OrbiMed Capital GP VI LLC | Dir, 10% | J - Other | — | +2.16M | 284.9K | New | — |
| MI | 2022-06-24 | 2022-06-22+ | IMA | ImageneBio, Inc. | OrbiMed Capital GP VI LLC | Dir | P - Purchase | $4.47 | -252.2K | 1.94M | -12% | -$1.13M |
| I | 2022-05-20 | 2022-05-18 | EWTX | Edgewise Therapeutics, Inc. | OrbiMed Capital GP VI LLC | Dir, 10% | P - Purchase | $7.21 | +138.0K | 13.50M | +1% | +$995.0K |
Purchase Sale Sale after option exercise All abbreviations